INVO Fertility (IVF) Revenue Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 39.21% |
| Jun 30, 2025 | 49.92% |
| Mar 31, 2025 | 44.65% |
| Dec 31, 2024 | 38.69% |
| Sep 30, 2024 | 36.40% |
| Jun 30, 2024 | 22.76% |
| Mar 31, 2024 | 52.77% |
| Dec 31, 2023 | 54.89% |
| Sep 30, 2023 | 50.79% |
| Jun 30, 2023 | 23.44% |
| Mar 31, 2023 | 27.29% |
| Dec 31, 2022 | 27.87% |
| Sep 30, 2022 | 28.10% |
| Jun 30, 2022 | 12.71% |
| Mar 31, 2022 | 25.49% |
| Dec 31, 2021 | 217.04% |
| Sep 30, 2021 | 65.12% |
| Jun 30, 2021 | 107.30% |
| Mar 31, 2021 | 106.78% |
| Sep 30, 2020 | 166.22% |
| Jun 30, 2020 | 113.47% |
| Mar 31, 2020 | 134.78% |
| Sep 30, 2019 | 129.65% |
| Jun 30, 2019 | 213.88% |
| Mar 31, 2019 | 81.29% |
| Dec 31, 2018 | 59.82% |
| Sep 30, 2018 | 234.85% |
| Jun 30, 2018 | 97.96% |
| Mar 31, 2018 | 65.94% |
| Dec 31, 2017 | 23.08% |
| Sep 30, 2017 | 79.86% |
| Jun 30, 2017 | 44.69% |
| Mar 31, 2017 | 35.87% |
| Dec 31, 2016 | 20.31% |
| Sep 30, 2016 | 6.72% |
| Jun 30, 2016 | -24.22% |